Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia (2017)

  • Authors:
  • USP affiliated authors: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
  • USP Schools: FMRP
  • DOI: 10.1007/s00277-017-3086-7
  • Subjects: MORTALIDADE; ANEMIA; COELHOS
  • Keywords: Early mortality; Overall survival; Rabbit antithymocyte globulin; Severe acquired aplastic anemia
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00277-017-3086-7 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ATTA, Elias H.; LIMA, Carlos B. L.; DIAS, Danielle S. P.; et al. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia. Annals of Hematology, New York, v. 96, n. 11, p. 1907-1914, 2017. Disponível em: < http://dx.doi.org/10.1007/s00277-017-3086-7 > DOI: 10.1007/s00277-017-3086-7.
    • APA

      Atta, E. H., Lima, C. B. L., Dias, D. S. P., Clé, D. V., Bonduel, M. M., Sciuccati, G. B., et al. (2017). Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia. Annals of Hematology, 96( 11), 1907-1914. doi:10.1007/s00277-017-3086-7
    • NLM

      Atta EH, Lima CBL, Dias DSP, Clé DV, Bonduel MM, Sciuccati GB, Medeiros LA, Oliveira MM, Salvino MA, Garanito MP, Fonseca PBB, Saad STO, Calado RT, Scheinberg P. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia [Internet]. Annals of Hematology. 2017 ; 96( 11): 1907-1914.Available from: http://dx.doi.org/10.1007/s00277-017-3086-7
    • Vancouver

      Atta EH, Lima CBL, Dias DSP, Clé DV, Bonduel MM, Sciuccati GB, Medeiros LA, Oliveira MM, Salvino MA, Garanito MP, Fonseca PBB, Saad STO, Calado RT, Scheinberg P. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia [Internet]. Annals of Hematology. 2017 ; 96( 11): 1907-1914.Available from: http://dx.doi.org/10.1007/s00277-017-3086-7

    Referências citadas na obra
    Scheinberg P, Young NS (2012) How I treat acquired aplastic anemia. Blood 120(6):1185–1196. doi: 10.1182/blood-2011-12-274019
    Passweg JR, Aljurf M (2013) Treatment and hematopoietic SCT in aplastic anemia. Bone Marrow Transplant 48(2):161. doi: 10.1038/bmt.2012.229
    Killick SB, Bown N, Cavenagh J et al (2016) Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol 172(2):187–207. doi: 10.1111/bjh.13853
    Scheinberg P, Nunez O, Weinstein B et al (2011) Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 365(5):430–438. doi: 10.1056/NEJMoa1103975
    Atta EH, Dias DS, Marra VL et al (2010) Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol 89(9):851–859. doi: 10.1007/s00277-010-0944-y
    Marsh JC, Bacigalupo A, Schrezenmeier H et al (2012) Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood 119(23):5391–5396. doi: 10.1182/blood-2012-02-407684
    Yoshimi A, Niemeyer CM, Fuhrer MM et al (2013) Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children. Blood 121(5):860–861. doi: 10.1182/blood-2012-10-461509
    Jeong DC, Chung NG, Cho B et al (2014) Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children. Haematologica 99(4):664–671. doi: 10.3324/haematol.2013.089268
    Feng X, Scheinberg P, Biancotto A et al (2014) In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia. Haematologica 99(9):1433–1440. doi: 10.3324/haematol.2014.106542
    Bacigalupo A, Hows J, Gluckman E et al (1988) Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol 70(2):177–182. doi: 10.1111/j.1365-2141.1988.tb02460.x
    Marsh JC, Bacigalupo A, Schrezenmeier H et al Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood 119(23):5391–5396. doi: 10.1182/blood-2012-02-407684
    Jeong DC, Chung NG, Cho B et al Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children. Haematologica 99(4):664–671. doi: 10.3324/haematol.2013.089268
    Scheinberg P, Fischer SH, Li L et al (2007) Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 109(8):3219–3224. doi: 10.1182/blood-2006-09-045625
    Locasciulli A, Oneto R, Bacigalupo A et al (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 92(1):11–18. doi: 10.3324/haematol.10075
    Scheinberg P, Wu CO, Nunez O et al (2009) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 144(2):206–216. doi: 10.1111/j.1365-2141.2008.07450.x
    Rosenfeld S, Follmann D, Nunez O et al (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289(9):1130–1135. doi: 10.1001/jama.289.9.1130
    Quillen K, Wong E, Scheinberg P et al (2009) Granulocyte transfusions in severe aplastic anemia: an eleven-year experience. Haematologica 94(12):1661–1668. doi: 10.3324/haematol.2009.010231
    O'Donghaile D, Childs RW, Leitman SF (2012) Blood consult: granulocyte transfusions to treat invasive aspergillosis in a patient with severe aplastic anemia awaiting mismatched hematopoietic progenitor cell transplantation. Blood 119(6):1353–1355. doi: 10.1182/blood-2011-10-345751
    Li X, Shi J, Ge M et al (2013) Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience. PLoS One 8(3):e56648. doi: 10.1371/journal.pone.0056648PONE-D-12-35108]
    Olnes MJ, Scheinberg P, Calvo KR et al (2012) Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med 367(1):11–19. doi: 10.1056/NEJMoa1200931
    Desmond R, Townsley DM, Dumitriu B et al (2014) Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood 123(12):1818–1825. doi: 10.1182/blood-2013-10-534743
    Jaime-Perez JC, Colunga-Pedraza PR, Gomez-Ramirez CD et al (2011) Danazol as first-line therapy for aplastic anemia. Ann Hematol 90(5):523–527. doi: 10.1007/s00277-011-1163-x
    Townsley DM, Dumitriu B, Young NS (2016) Danazol treatment for telomere diseases. N Engl J Med 375(11):1095–1096. doi: 10.1056/NEJMc1607752
    Esteves I, Bonfim C, Pasquini R et al Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study. Bone Marrow Transplant 50(5):685–689. doi: 10.1038/bmt.2015.20
    Scheinberg P, Cooper JN, Sloand EM et al (2010) Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA 304(12):1358–1364. doi: 10.1001/jama.2010.1376
    Yoshizato T, Dumitriu B, Hosokawa K et al (2015) Somatic mutations and clonal hematopoiesis in aplastic anemia. N Engl J Med 373(1):35–47. doi: 10.1056/NEJMoa1414799
    Medeiros LA, Pasquini R (2010) Anemia aplásica adquirida e anemia de Fanconi - Diretrizes Brasileiras em Transplante de Células-Tronco Hematopoiéticas. Rev Bras Hematol Hemoter 32:40–45. doi: 10.1590/S1516-84842010005000064